B Cell Trophic Factors and B Cell Antagonism in Autoimmune DiseaseAvailable to Purchase
The understanding of B cell biology has increased and expanded enormously in the last three decades. It is now known that B cells, in addition to just differentiating into antibody-secreting cells, serve many other vital functions. For example, their roles as antigen-presenting cells and cytokine-producing cells as well as effector cells and regulatory cells are well appreciated now. Indeed, the pathologic role of B cells in many autoimmune disorders may be largely autoantibody-independent. Today, the B cell is of considerable interest not only to immunologists but also to mainstream clinicians and scientists. The current volume covers the latest information on the functions of B cells in normal and disease states, and their therapeutic antagonism. Chapters cover cutting-edge topics from the basic to the clinical, including B cells in infection and autoimmunity, CD19-CD21 signal transduction complex, marginal zone B cell physiology and disease, B cell growth and differentiation, their role in rheumatoid arthritis, SLE treatment, the BAFF/APRIL system and B lymphocyte malignancies. This book is recommended reading for cellular and molecular immunologists as well as for rheumatologists, hematologists and clinical immunologists, and all those interested in human diseases in which B cells play an important contributory role.
Download citation file:
Digital Version
Print Version
Table of Contents
-
1 - 24: Determinations of B Cell Fate in Immunity and AutoimmunityByRandolph J. Noelle,;Randolph J. Noelle,Department of Microbiology and Immunology,Dartmouth Medical School, Lebanon, N.H., USASearch for other works by this author on:Loren D. EricksonLoren D. EricksonDepartment of Microbiology and Immunology,Dartmouth Medical School, Lebanon, N.H., USASearch for other works by this author on:
-
25 - 54: Regulatory Roles for Cytokine- Producing B Cells in Infection and Autoimmune DiseaseByFrances E. Lund;Frances E. LundaTrudeau Institute, Saranac Lake, N.Y. andSearch for other works by this author on:Beth A. Garvy;Beth A. GarvybDepartment of Microbiology,Immunology and Molecular Genetics, University of Kentucky,Chandler Medical School, Lexington, Ky., USASearch for other works by this author on:Troy D. Randall;Troy D. RandallaTrudeau Institute, Saranac Lake, N.Y. andSearch for other works by this author on:David P. HarrisDavid P. HarrisaTrudeau Institute, Saranac Lake, N.Y. andSearch for other works by this author on:
-
55 - 90: The CD19-CD21 Signal Transduction Complex of B Lymphocytes Regulates the Balance between Health and Autoimmune Disease: Systemic Sclerosis as a Model SystemByThomas F. Tedder;Thomas F. TedderaDepartment of Immunology, Duke University Medical Center, Durham, N.C., USA;Search for other works by this author on:Jonathan C. Poe;Jonathan C. PoeaDepartment of Immunology, Duke University Medical Center, Durham, N.C., USA;Search for other works by this author on:Manabu Fujimoto;Manabu FujimotobDepartment of Dermatology, Faculty of Medicine, University of Tokyo, Bunkyo,Tokyo, andSearch for other works by this author on:Karen M. Haas;Karen M. HaasaDepartment of Immunology, Duke University Medical Center, Durham, N.C., USA;Search for other works by this author on:Shinichi SatoShinichi SatocDepartment of Dermatology, Kanazawa University Graduate School of Medical Science, Ishikawa, Kanazawa, JapanSearch for other works by this author on:
-
91 - 123: Marginal Zone B Cell Physiology and DiseaseByThiago Lopes-Carvalho;Thiago Lopes-CarvalhoDivision of Clinical and Developmental Immunology, Department of Microbiology, University of Alabama at Birmingham, Birmingham, Ala., USASearch for other works by this author on:John F. KearneyJohn F. KearneyDivision of Clinical and Developmental Immunology, Department of Microbiology, University of Alabama at Birmingham, Birmingham, Ala., USASearch for other works by this author on:
-
124 - 139: Dendritic Cells Control B Cell Growth and DifferentiationByGaetan Jego;Gaetan JegoBaylor Institute for Immunology Research and Baylor NIAID Cooperative Center for Translational Research on Human Immunology and Biodefense, Dallas, Tex., USASearch for other works by this author on:Virginia Pascual;Virginia PascualBaylor Institute for Immunology Research and Baylor NIAID Cooperative Center for Translational Research on Human Immunology and Biodefense, Dallas, Tex., USASearch for other works by this author on:A. Karolina Palucka;A. Karolina PaluckaBaylor Institute for Immunology Research and Baylor NIAID Cooperative Center for Translational Research on Human Immunology and Biodefense, Dallas, Tex., USASearch for other works by this author on:Jacques BanchereauJacques BanchereauBaylor Institute for Immunology Research and Baylor NIAID Cooperative Center for Translational Research on Human Immunology and Biodefense, Dallas, Tex., USASearch for other works by this author on:
-
140 - 174: The Biology of CD20 and Its Potential as a Target for mAb TherapyByMark S. Cragg;Mark S. CraggTenovus Research Laboratory, Cancer Sciences Division, Southampton University,Southampton General Hospital, Southampton, UKSearch for other works by this author on:Claire A. Walshe;Claire A. WalsheTenovus Research Laboratory, Cancer Sciences Division, Southampton University,Southampton General Hospital, Southampton, UKSearch for other works by this author on:Andrey O. Ivanov;Andrey O. IvanovTenovus Research Laboratory, Cancer Sciences Division, Southampton University,Southampton General Hospital, Southampton, UKSearch for other works by this author on:Martin J. GlennieMartin J. GlennieTenovus Research Laboratory, Cancer Sciences Division, Southampton University,Southampton General Hospital, Southampton, UKSearch for other works by this author on:
-
175 - 192: B Lymphocyte Depletion in Rheumatoid Arthritis:Targeting of CD20ByJonathan C.W. Edwards;Jonathan C.W. EdwardsCentre for Rheumatology, University College London, London, UKSearch for other works by this author on:Maria J. Leandro;Maria J. LeandroCentre for Rheumatology, University College London, London, UKSearch for other works by this author on:Geraldine CambridgeGeraldine CambridgeCentre for Rheumatology, University College London, London, UKSearch for other works by this author on:
-
193 - 205: Treatment of SLE with Anti-CD20 Monoclonal AntibodyByR. John Looney;R. John LooneyAllergy Immunology, Rheumatology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, N.Y., USASearch for other works by this author on:Jennifer Anolik;Jennifer AnolikAllergy Immunology, Rheumatology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, N.Y., USASearch for other works by this author on:Inaki SanzInaki SanzAllergy Immunology, Rheumatology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, N.Y., USASearch for other works by this author on:
-
206 - 242: The Biochemistry and Biology of BAFF, APRIL and Their ReceptorsBySusan L. Kalled;Susan L. KalledBiogen Idec, Inc., Cambridge, Mass., USASearch for other works by this author on:Christine Ambrose;Christine AmbroseBiogen Idec, Inc., Cambridge, Mass., USASearch for other works by this author on:Yen-Ming HsuYen-Ming HsuBiogen Idec, Inc., Cambridge, Mass., USASearch for other works by this author on:
-
243 - 265: The BAFF/APRIL System: An Important Player in Systemic Rheumatic DiseasesByFabienne Mackay;Fabienne MackayaThe Garvan Institute of Medical Research, Department of Arthritis and Inflammation, Darlinghurst, andSearch for other works by this author on:Frederic Sierro;Frederic SierroaThe Garvan Institute of Medical Research, Department of Arthritis and Inflammation, Darlinghurst, andSearch for other works by this author on:Shane T. Grey;Shane T. GreyaThe Garvan Institute of Medical Research, Department of Arthritis and Inflammation, Darlinghurst, andSearch for other works by this author on:Tom P. GordonTom P. GordonbDepartment of Immunology, Arthritis and Allergy, Flinders Medical Centre, Bedford Park, AustraliaSearch for other works by this author on:
-
266 - 288: Human B Lymphocyte Malignancies: Exploitation of BLyS and APRIL and Their ReceptorsByDiane F. Jelinek;Diane F. JelinekDepartment of Immunology, Mayo Graduate School, Mayo Clinic College of Medicine, Rochester, Minn., USASearch for other works by this author on:Jaime R. DarceJaime R. DarceDepartment of Immunology, Mayo Graduate School, Mayo Clinic College of Medicine, Rochester, Minn., USASearch for other works by this author on:
-
289 - 304: BlySfulness Does Not Equal Blissfulness in Systemic Lupus Erythematosus: A Therapeutic Role for BLyS AntagonistsByWilliam StohlWilliam StohlDivision of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, Calif., USASearch for other works by this author on: